{"id":"tp-60504","type":"article-newspaper","title":"Apimeds Pharmaceuticals US, Inc. Posts $2.89 Million Revenue and $7.68 Diluted GAAP EPS","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/60504","datePublished":"2026-11-18T14:11:15.000Z","dateModified":"2026-11-18T14:11:15.000Z","language":"en","abstract":"Third-quarter basic GAAP EPS was $19.13.","section":"Business","references":[]}